A phase I/II trial of SP 102 inpatients with lumbar radiculopathy
Phase of Trial: Phase I/II
Latest Information Update: 26 Jun 2017
At a glance
- Drugs SP 102 (Primary)
- Indications Radiculopathy
- Focus Adverse reactions; First in man; Proof of concept
- 26 Jun 2017 According to a Semnur Pharmaceuticals media release, detailed data from this trial is expected at upcoming meetings.
- 26 Jun 2017 Status changed from recruiting to completed, according to a Semnur Pharmaceuticals media release.
- 26 Jun 2017 Data from this trial published in a Semnur Pharmaceuticals Media Release.